 Christine Vohwinkel
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Lung Injury | 7 | 2023 | 305 | 2.790 |
Why?
| | Pneumonia | 2 | 2022 | 636 | 0.930 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-2 | 3 | 2017 | 6 | 0.760 |
Why?
| | Respiration, Artificial | 2 | 2026 | 713 | 0.730 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2026 | 390 | 0.700 |
Why?
| | Succinate Dehydrogenase | 1 | 2021 | 65 | 0.660 |
Why?
| | Macrophages, Alveolar | 1 | 2023 | 373 | 0.640 |
Why?
| | Pulmonary Alveoli | 3 | 2021 | 385 | 0.630 |
Why?
| | Glycogen Synthase Kinase 3 beta | 2 | 2017 | 74 | 0.630 |
Why?
| | Lung | 9 | 2023 | 4106 | 0.620 |
Why?
| | ELAV-Like Protein 1 | 1 | 2017 | 17 | 0.510 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2022 | 296 | 0.500 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2021 | 411 | 0.470 |
Why?
| | RNA Stability | 1 | 2017 | 107 | 0.470 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2016 | 30 | 0.470 |
Why?
| | Hypercapnia | 2 | 2013 | 53 | 0.440 |
Why?
| | Ion Channels | 2 | 2013 | 129 | 0.420 |
Why?
| | Viral Matrix Proteins | 1 | 2013 | 28 | 0.390 |
Why?
| | Phosphofructokinase-2 | 2 | 2022 | 16 | 0.360 |
Why?
| | Disease Models, Animal | 3 | 2018 | 4560 | 0.330 |
Why?
| | Carbon Dioxide | 1 | 2011 | 227 | 0.300 |
Why?
| | Animals | 17 | 2023 | 38030 | 0.300 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2013 | 371 | 0.290 |
Why?
| | RNA, Messenger | 1 | 2017 | 2803 | 0.280 |
Why?
| | Alveolar Epithelial Cells | 2 | 2023 | 121 | 0.280 |
Why?
| | Up-Regulation | 1 | 2011 | 847 | 0.280 |
Why?
| | Hypoxia | 2 | 2016 | 1199 | 0.280 |
Why?
| | Inflammation | 4 | 2023 | 2878 | 0.270 |
Why?
| | Hydrochloric Acid | 2 | 2018 | 9 | 0.270 |
Why?
| | MicroRNAs | 3 | 2022 | 686 | 0.260 |
Why?
| | Lipopolysaccharides | 2 | 2023 | 858 | 0.260 |
Why?
| | Mice | 9 | 2023 | 18329 | 0.250 |
Why?
| | Ventilator-Induced Lung Injury | 2 | 2018 | 61 | 0.240 |
Why?
| | Positive-Pressure Respiration | 1 | 2026 | 115 | 0.220 |
Why?
| | Transforming Growth Factor beta | 2 | 2017 | 474 | 0.210 |
Why?
| | Mitochondria | 1 | 2011 | 992 | 0.210 |
Why?
| | Cell Proliferation | 1 | 2011 | 2507 | 0.200 |
Why?
| | Postoperative Complications | 1 | 2016 | 2970 | 0.190 |
Why?
| | Signal Transduction | 2 | 2021 | 5216 | 0.190 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2023 | 26 | 0.190 |
Why?
| | Humans | 22 | 2026 | 145474 | 0.180 |
Why?
| | Lactic Acid | 1 | 2023 | 295 | 0.180 |
Why?
| | Period Circadian Proteins | 1 | 2022 | 33 | 0.180 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 21 | 0.170 |
Why?
| | Acid-Base Equilibrium | 1 | 2021 | 23 | 0.170 |
Why?
| | Endocytosis | 3 | 2017 | 168 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5983 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 1 | 2023 | 477 | 0.150 |
Why?
| | Acidosis | 1 | 2021 | 105 | 0.150 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 251 | 0.150 |
Why?
| | Coronary Vessels | 1 | 2021 | 246 | 0.150 |
Why?
| | Receptor, EphA2 | 1 | 2018 | 17 | 0.140 |
Why?
| | Endothelial Cells | 2 | 2021 | 874 | 0.140 |
Why?
| | Pulmonary Edema | 1 | 2017 | 105 | 0.130 |
Why?
| | A549 Cells | 1 | 2017 | 75 | 0.130 |
Why?
| | Heart Ventricles | 1 | 2021 | 756 | 0.120 |
Why?
| | Cytokines | 1 | 2023 | 2067 | 0.120 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2188 | 0.110 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 125 | 0.110 |
Why?
| | Hyperammonemia | 1 | 2015 | 17 | 0.110 |
Why?
| | Methanol | 1 | 2015 | 44 | 0.110 |
Why?
| | Inflammation Mediators | 2 | 2015 | 506 | 0.110 |
Why?
| | Lung Injury | 1 | 2018 | 244 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2021 | 3124 | 0.100 |
Why?
| | Pneumonia, Bacterial | 1 | 2013 | 113 | 0.090 |
Why?
| | Serum Albumin, Bovine | 1 | 2012 | 62 | 0.090 |
Why?
| | Ketoglutaric Acids | 1 | 2011 | 22 | 0.090 |
Why?
| | Endothelium, Vascular | 1 | 2018 | 956 | 0.090 |
Why?
| | Infant | 1 | 2026 | 10077 | 0.090 |
Why?
| | Muscular Dystrophies | 1 | 2011 | 28 | 0.090 |
Why?
| | Transfection | 1 | 2013 | 926 | 0.080 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2011 | 72 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 1 | 2013 | 395 | 0.080 |
Why?
| | Cell Line | 3 | 2011 | 2823 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1957 | 0.080 |
Why?
| | Respiratory Mucosa | 1 | 2012 | 322 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2021 | 6447 | 0.070 |
Why?
| | Child | 3 | 2026 | 22707 | 0.070 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2009 | 55 | 0.070 |
Why?
| | Lysosomes | 1 | 2009 | 131 | 0.070 |
Why?
| | Neutrophils | 1 | 2013 | 1124 | 0.070 |
Why?
| | Smith-Lemli-Opitz Syndrome | 1 | 2007 | 17 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2018 | 4148 | 0.060 |
Why?
| | Simvastatin | 1 | 2007 | 59 | 0.060 |
Why?
| | Cell Membrane Permeability | 2 | 2018 | 88 | 0.060 |
Why?
| | Cell Membrane | 3 | 2017 | 707 | 0.060 |
Why?
| | Cholesterol | 1 | 2007 | 408 | 0.060 |
Why?
| | Receptors, Glycine | 1 | 2004 | 5 | 0.050 |
Why?
| | Myoclonus | 1 | 2004 | 16 | 0.050 |
Why?
| | Lung Diseases | 1 | 2011 | 780 | 0.050 |
Why?
| | Protein Kinase C | 2 | 2017 | 251 | 0.050 |
Why?
| | Thermodynamics | 1 | 2004 | 419 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2021 | 65 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2023 | 308 | 0.040 |
Why?
| | Female | 6 | 2021 | 78844 | 0.040 |
Why?
| | Computer Simulation | 1 | 2004 | 1003 | 0.040 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 192 | 0.040 |
Why?
| | Models, Molecular | 1 | 2004 | 1598 | 0.040 |
Why?
| | Rats | 3 | 2013 | 5584 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2023 | 451 | 0.040 |
Why?
| | Phosphorylation | 2 | 2016 | 1707 | 0.040 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 56 | 0.030 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2018 | 140 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2022 | 512 | 0.030 |
Why?
| | Lipoproteins, LDL | 1 | 2017 | 119 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2017 | 95 | 0.030 |
Why?
| | Bleomycin | 1 | 2018 | 255 | 0.030 |
Why?
| | Male | 4 | 2018 | 72842 | 0.030 |
Why?
| | Proteolysis | 1 | 2017 | 172 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1891 | 0.030 |
Why?
| | Hydroxylation | 1 | 2016 | 47 | 0.030 |
Why?
| | Cohort Studies | 2 | 2022 | 6013 | 0.030 |
Why?
| | Critical Illness | 1 | 2022 | 900 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 442 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 618 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2015 | 100 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 305 | 0.030 |
Why?
| | Epithelial Cells | 2 | 2012 | 1131 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2015 | 218 | 0.030 |
Why?
| | Acidosis, Respiratory | 1 | 2013 | 3 | 0.030 |
Why?
| | HL-60 Cells | 1 | 2013 | 30 | 0.030 |
Why?
| | Bacterial Load | 1 | 2013 | 67 | 0.020 |
Why?
| | Electroporation | 1 | 2013 | 43 | 0.020 |
Why?
| | Electric Impedance | 1 | 2013 | 108 | 0.020 |
Why?
| | Solutions | 1 | 2013 | 159 | 0.020 |
Why?
| | Nuclear Envelope | 1 | 2013 | 45 | 0.020 |
Why?
| | Primary Cell Culture | 1 | 2013 | 172 | 0.020 |
Why?
| | Plasmids | 1 | 2013 | 373 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 337 | 0.020 |
Why?
| | Phagocytosis | 1 | 2013 | 296 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 652 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 637 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4295 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1508 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1261 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 611 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1048 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1100 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 8057 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 776 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2597 | 0.020 |
Why?
| | Half-Life | 1 | 2009 | 155 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1217 | 0.020 |
Why?
| | Ubiquitination | 1 | 2009 | 118 | 0.020 |
Why?
| | Suicide | 1 | 2015 | 728 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 407 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2524 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2009 | 666 | 0.010 |
Why?
| | Kinetics | 1 | 2009 | 1567 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3542 | 0.010 |
Why?
| | Child, Preschool | 1 | 2021 | 11853 | 0.010 |
Why?
| | Helix-Turn-Helix Motifs | 1 | 2004 | 5 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2007 | 217 | 0.010 |
Why?
| | Stiff-Person Syndrome | 1 | 2004 | 14 | 0.010 |
Why?
| | Reflex, Startle | 1 | 2004 | 75 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 229 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2004 | 376 | 0.010 |
Why?
| | Patch-Clamp Techniques | 1 | 2004 | 289 | 0.010 |
Why?
| | Glycine | 1 | 2004 | 186 | 0.010 |
Why?
| | Neural Inhibition | 1 | 2004 | 178 | 0.010 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 443 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2007 | 583 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 7123 | 0.010 |
Why?
| | Genotype | 1 | 2007 | 1852 | 0.010 |
Why?
| | Protein Conformation | 1 | 2004 | 938 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2028 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 22529 | 0.010 |
Why?
|
|
Vohwinkel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|